MISMATCH REPAIR DEFICIENCY
Clinical trials for MISMATCH REPAIR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral drug called Alintegimod, given alongside standard immunotherapy drugs (ipilimumab and nivolumab), for people with advanced cancers that have spread. The main goals are to find a safe dose and see if the combination helps control the cancer. It is …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New approach could help surgeons save organs in tough colon cancer cases
Disease control Recruiting nowThis study is testing whether giving immunotherapy drugs before surgery can help surgeons completely remove advanced colon tumors while preserving nearby organs. It focuses on patients whose cancer has a specific genetic feature that makes it respond poorly to standard chemothera…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Simple blood test could revolutionize colon cancer screening
Diagnosis Recruiting nowThis study is testing a new blood test to see if it can accurately detect colorectal cancer and precancerous growths called adenomas. It aims to provide a less invasive screening option to help find these conditions earlier. The test will also be evaluated for people with Lynch s…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Sponsor: San Raffaele University • Aim: Diagnosis
Last updated Mar 13, 2026 15:06 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC